Latest News Archive
Please select Category, Year, and then Month to display items
24 January 2021
|
Story Lacea Loader
FARMOVS, a wholly owned clinical research company of the University of the Free State (UFS), together with several medical and scientific experts at the university, is currently in the process of preparing a clinical trial protocol to determine the efficacy of Ivermectin for COVID-19 in a randomised, controlled study according to the requirements of the legal professions, in order to submit it for approval to the relevant national regulatory authority.
FARMOVS is a South African specialty full-service clinical research organisation conducting ICH-GCP-compliant Phase I to IV clinical trials. FARMOVS’ competitive advantage is its wealth of bioequivalence and Phase I experience and expertise, patient recruitment success, and a clinical research facility with the only onsite ISO (International Organization for Standardization) and GLP (Good Laboratory Practice) certified bioanalytical laboratory on the African continent.
By participating in the preparation of the clinical trial protocol, FARMOVS and the UFS remain supportive of and committed to contributing to the development of treatments and treatment strategies to battle the COVID-19 pandemic. Should the clinical trial protocol be approved by the relevant national regulatory authority, the UFS will be the first university in South Africa to attempt such a study.
The university management is aware of a WhatsApp voice clip being circulated, in which reference is made to a particular meeting, and mention is made of the role the institution is playing in establishing the efficacy of Ivermectin for COVID-19. The voice clip is premature and was shared with a small group, from where it went viral. The voice clip is also not factual – specifically regarding the university and its alleged opinion pertaining to the usage and need for scientific investigation into the matter.
The UFS is committed to rigorous science and evidence-based research, and both FARMOVS and the university fully support the published opinions and guidelines of the South African Health Products Regulatory Authority (SAHPRA) and the scientific advisory boards established by the scientific community, as well as the stance of the South African government on Ivermectin for COVID-19.
Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Kovsie-Alumni Trust awards bursaries to the top matriculants
2006-05-13
Every year, the Kovsie-Alumni Trust of the University of the Free State (UFS) awards bursaries to the top matriculants from each province who study at the UFS. The top matriculants in the Free State and Northern Cape are studying at the UFS this year.
At the awarding of the bursaries were from the left Ms Liné Morrison (top matriculant in the Free State in 2005), Ms Frances Hoexter (Chairperson of the Kovsie-Alumni Trust) and Ms Liesl-Barbara Muller (top matriculant in the Northern Cape in 2005). Me Morrison matriculated from the Secondary School Witteberg in Bethlehem and studies B Sc (Physiotherapy). Ms Muller is a MB Ch B student who matriculated from the Secondary School Diamantveld in Kimberley.